EUVIMEDObjevte EUVIMED
Crossref

The adiponectin receptor agonist AdipoAI attenuates periodontitis in diabetic rats by inhibiting gingival fibroblast‐induced macrophage migration

Wei Qiu, Zhaodan Wang, Zehao Chen, Qian Sun, Hongle Wu, Zhao Chen, Kaiqi Luan, Zining Liu, Dian Ding, Qisheng Tu iD, Jake Chen, Buling Wu and 1 more

British Journal of Pharmacology · 2023-09 · 180 (18) · 2436-2451

DOI: 10.1111/bph.16103 ↗

At a glance

Journal article in British Journal of Pharmacology, 2023-06. Written by Wei Qiu and 12 co-authors. Institution: Department of Stomatology, Nanfang Hospital, Southern Medical University, Guangzhou, China. Major MEDLINE topics: Diabetes Mellitus, Experimental, Periodontitis, Alveolar Bone Loss, Insulins. Cited 14 times so far (Crossref); 50 references. Funded by: National Natural Science Foundation of China, Natural Science Foundation of Guangdong Province.

AbstraktSubjectsBibliografické údajeCiteRelated studies

Abstract (original language)

Background and Purpose Low‐grade inflammation, a common feature of both diabetes and periodontitis, partly accounts for the complexity and refractoriness of diabetes‐associated periodontitis. Adiponectin (APN), the most abundant adipokine in human blood, has been widely reported to have anti‐inflammatory functions. Herein, we investigated the ability of an APN receptor agonist, AdipoAI, to alleviate diabetes‐associated periodontitis. Furthermore, we revealed the possible mechanism underlying its anti‐inflammatory effects. Experimental Approach The maxillary first molar of Zucker diabetic fatty (ZDF) rats was ligated to construct a diabetes‐associated periodontitis model, and rats were administered AdipoAI by gavage. We examined diabetes‐related indexes, pathological changes in insulin target organs, alveolar bone resorption and systemic and local inflammation. In vitro, transwell assays were used to evaluate monocyte/macrophage migration induced by human gingival fibroblasts (hGFs) with/without AdipoAI treatment. Additionally, we examined chemokine expression levels in hGFs and hGF‐induced monocyte/macrophage migration upon siRNA knockdown of Adiponectin receptor expression. Expression of Adipo1/Adipo2 receptors and inflammation‐related signalling pathways were examined by IHC and WB, followed by confirmation with an NF‐κB P65 inhibitor (BAY 11‐7082). Key Results AdipoAI lowered fasting blood glucose and serum insulin in ZDF rats and alleviated inflammation in insulin target tissues. Locally, AdipoAI reduced alveolar bone absorption and gingival inflammation. Mechanistically, AdipoAI inhibited hGF‐induced monocyte/macrophage migration by reducing CCL2 secretion. In hGFs, AdipoAI attenuated LPS‐induced activation of NF‐κB P65 and CCL2 expression, which was dependent on the Adipo receptor 1. Conclusion and Implications AdipoAI, with its ability to alleviate inflammatory damage in tissues, is a candidate for diabetes‐associated periodontitis treatment.

Subjects

MeSH terms (MEDLINE)

Diabetes Mellitus, ExperimentalPeriodontitisAlveolar Bone LossInsulinsRatsHumansAnimalsAdiponectinReceptors, AdiponectinNF-kappa BRats, ZuckerInflammationMacrophagesFibroblastsLipopolysaccharides

Author keywords

Adipo receptorsAdipoAIadiponectinanti-inflammationdiabetes-associated periodontitishuman gingival fibroblasts

Substances

AdiponectinReceptors, AdiponectinNF-kappa BInsulinsLipopolysaccharides

Authors and institutions

  • Department of Stomatology, Nanfang Hospital, Southern Medical University, Guangzhou, China.
  • Department of Endodontics, Stomatological Hospital, School of Stomatology, Southern Medical University, Guangzhou, China.
  • Division of Oral Biology, Tufts University School of Dental Medicine, Boston, Massachusetts, USA.

ORCID profiles: Qisheng Tu, Fuchun Fang

Funding

  • National Natural Science Foundation of China
  • Natural Science Foundation of Guangdong Province

Cite

APA

Qiu, W., Wang, Z., Chen, Z., Sun, Q., Wu, H., Chen, Z., Luan, K., Liu, Z., Ding, D., Tu, Q., Chen, J., Wu, B., & Fang, F. (2023). The adiponectin receptor agonist AdipoAI attenuates periodontitis in diabetic rats by inhibiting gingival fibroblast‐induced macrophage migration. British Journal of Pharmacology, 180(18), 2436-2451. https://doi.org/10.1111/bph.16103

Vancouver

Qiu W, Wang Z, Chen Z, Sun Q, Wu H, Chen Z, et al. The adiponectin receptor agonist AdipoAI attenuates periodontitis in diabetic rats by inhibiting gingival fibroblast‐induced macrophage migration. British Journal of Pharmacology. 2023;180(18):2436-2451. doi:10.1111/bph.16103

BibTeX
@article{Qiu2023,
  author = {Qiu, Wei and Wang, Zhaodan and Chen, Zehao and Sun, Qian and Wu, Hongle and Chen, Zhao and Luan, Kaiqi and Liu, Zining and Ding, Dian and Tu, Qisheng and Chen, Jake and Wu, Buling and Fang, Fuchun},
  title = {The adiponectin receptor agonist AdipoAI attenuates periodontitis in diabetic rats by inhibiting gingival fibroblast‐induced macrophage migration},
  journal = {British Journal of Pharmacology},
  year = {2023},
  volume = {180},
  number = {18},
  pages = {2436--2451},
  doi = {10.1111/bph.16103}
}
Start for free →